All Press Releases for March 04, 2020

Mei-Ying Wong Yu, PhD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who

Dr. Yu has been endorsed by Marquis Who's Who as a leader in the pharmacology field

Dr. Mei-Ying Wong Yu had an impressive number of international collaborations and as a result safety and potency standards for the WHO, EDQM and CBER/FDA have been developed.

    ROCKVILLE, MD, March 04, 2020 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Mei-Ying Wong Yu, PhD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Yu celebrates many years' experience in her professional network, and has been noted for achievements, leadership qualities, and the credentials and successes she has accrued in her field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Yu was a highly accomplished and experienced senior-level scientist in CBER (Center for Biologic Evaluation and Research), one of the six main Centers within the FDA (Food and Drug Administration), with nearly 40 years of excellence in her field. She initially pursued an education at Kaohsiung Medical College in Taiwan, where she earned a Bachelor of Science in pharmacy in 1964 and subsequently was certified by the Taiwanese Pharmacist Association. Upon receiving an opportunity to study in the United States, she concluded her academic efforts at the University of Alabama, Birmingham, obtaining a Master of Science in pharmacology in 1968 and a Doctor of Philosophy in pharmacology in 1970.

From 1964 to 1970, Dr. Yu began her career as a research assistant in Department of Pharmacology at the University of Alabama, Birmingham. She later completed a postdoctoral fellowship at the Baylor College of Medicine, Houston, from 1970 to 1971. From 1971 to 1974, she worked as a research associate at the University of Texas, Austin. From 1974 to 1980, Dr. Yu served as a senior staff fellow at the National Institutes of Health, Bethesda.

Dr. Yu joined CBER as a senior staff fellow in Division of Blood and Blood Products in 1980 but soon excelled as a research chemist and became a principal investigator from 1981 to 2000. She was supervisory research chemist and a senior investigator from 2000 to 2011, at which point she retired and served as a volunteer/emeritus until 2014. Notably Dr. Yu conducted and supervised research and regulatory work for assuring safety, potency and purity of plasma-derived products, such as intravenous or subcutaneous immunoglobulin products for treating primary immunodeficiency. She was recognized as an expert in viral safety of blood and plasma products with respect to hepatitis viruses and parvovirus B19, which was evident on the basis of her numerous publications, public presentations, quality of collaborations, and international leadership role. She had an impressive number of international collaborations and as a result safety and potency standards for the WHO (World Health Organization), EDQM (European Directorate for the Quality of Medicines & HealthCare), and CBER/FDA have been developed.

In light of her exceptional undertakings, Dr. Yu has received many awards for her work, including a 1997 FDA Award of Merit for her scientific expertise to investigate and safeguard the viral safety of plasma derived products with respect to hepatitis C transmission, a 2009 FDA Award of Merit for her internationally recognized leadership in development and implementation of standards to enhance viral safety, clinical safety and efficacy of blood products, and several other award citations from CBER, FDA and HHS (Health and Human Services) over the years.
Furthermore, Dr. Yu was one of USP (United States Pharmacopoeia) Expert Panel members in preparing USP _1240_Viral Testing Safety for Human Plasma Designated for Further Manufacturing, 2010 - 2015. She also served as a member of the scientific advisory board for the Taiwan Food and Drug Administration, 2010 - 2013.

About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at

# # #

Contact Information

-- --
Marquis Who's Who Ventures LLC
Uniondale, NY
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: